Clinical Trial Update: Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Buzzard Pharmaceuticals' Phase 1 and Phase 2 trials tested isunakinra alone and in combination with a PD-1/PD-L1 inhibitor in adults with cancer. The trials hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Isunakinra (isunakinra)
• PD-1/PD-L1 inhibitor

Snippet

Sponsor: Buzzard Pharmaceuticals | Conditions: Solid Tumor, Adult | Phase 1, Phase 2 | Status: COMPLETED